Shedding of human tumor-associated antigens in vitro and in vivo
Herlyn, M.; Rodeck, U.; Koprowski, H.
Advances in Cancer Research 49: 189-221
1987
ISSN/ISBN: 0065-230X PMID: 3314394 Document Number: 298994
Document emailed within 1 workday
Related Documents
Herberman, R.B. 1973: In vivo and in vitro assays of cellular immunity to human tumor antigens Federation Proceedings 32(2): 160-164Giacomini, P.; Aguzzi, A.; Pestka, S.; Fisher, P.B.; Ferrone, S. 1984: Modulation by recombinant DNA leukocyte (alpha) and fibroblast (beta) interferons of the expression and shedding of HLA- and tumor-associated antigens by human melanoma cells Journal of Immunology 133(3): 1649-1655
Hostetler, L.W.; Romerdahl, C.A.; Kripke, M.L. 1989: Specificity of antigens on UV radiation-induced antigenic tumor cell variants measured in vitro and in vivo Cancer Research 49(5): 1207-1213
Musatov, M.I.; Kozhevnikov, V.S.; Konenkov, V.I.; Lozovoĭ, V.P. 1987: Time dependence of the shedding of class i and Ii HLA antigens. Interrelation of the fluctuations of HLA-antigen shedding and 51Cr-labeled macromolecules Biulleten' Eksperimental'noi Biologii i Meditsiny 104(9): 327-329
Proost, P.; De Wolf-Peeters, C.; Conings, R.; Opdenakker, G.; Billiau, A.; Van Damme, J. 1993: Identification of a novel granulocyte chemotactic protein (GCP-2) from human tumor cells. in vitro and in vivo comparison with natural forms of GRO, IP-10, and IL-8 Journal of Immunology 150(3): 1000-1010
Ménard, S.; Colnaghi, M.I.; Della Porta, G. 1973: In vitro demonstration of tumor-specific common antigens and embryonal antigens in murine fibrosarcomas induced by 7,12-dimethylbenz(a)anthracene Cancer Research 33(3): 478-481
Tosi, P.; Calabresi, P.; Goulette, F.A.; Renaud, C.A.; Darnowski, J.W. 1992: Azidothymidine-induced cytotoxicity and incorporation into DNA in the human colon tumor cell line HCT-8 is enhanced by methotrexate in vitro and in vivo Cancer Research 52(15): 4069-4073
Otsuka, Y.; Nagano, K.; Nagano, K.; Hori, K.; Oh-ishi, J.; Hayashi, H.; Watanabe, N.; Niitsu, Y. 1990: Inhibition of neutrophil migration by tumor necrosis factor. Ex vivo and in vivo studies in comparison with in vitro effect Journal of Immunology 145(8): 2639-2643
Carter, R.H.; Drebin, J.A.; Schatten, S.; Perry, L.L.; Greene, M.I. 1983: Regulation of the immune response to tumor antigens. IX. in vitro Lyt-1+2- cell proliferative responses to cellbound or subcellular tumor antigen Journal of Immunology 130(2): 997-1002
Remennik, L.V.; Litvinov, S.V.; Kriukova, I.N.; Chuev, I.V. 1985: Expression of antigens immunologically related to the antigens of the mouse mammary tumor virus in the tissue of human breast tumors Biulleten' Eksperimental'noi Biologii i Meditsiny 99(6): 734-736
Herlyn, M.; Guerry, D.; Koprowski, H. 1985: Recombinant gamma-interferon induces changes in expression and shedding of antigens associated with normal human melanocytes, nevus cells, and primary and metastatic melanoma cells Journal of Immunology 134(6): 4226-4230
Imai, K.; Ng, A.K.; Glassy, M.C.; Ferrone, S. 1981: Differential effect of interferon on the expression of tumor-associated antigens and histocompatibility antigens on human melanoma cells: relationship to susceptibility to immune lysis mediated by monoclonal antibodies Journal of Immunology 127(2): 505-509
Guo, H.Y.; Colangelo, D.; Li, L.; Connors, K.M.; Kubota, T.; Hoffman, R.M. 1992: In vitro histoculture of human tumors with fluorescent dye end-points measured by confocal microscopy: high correlation of in vitro and in vivo chemosensitivity Anticancer Research 12(4): 1055-1061
Song, S.; Suzuki, H.; Terasaki, T.; Lemaire, M.; Sugiyama, Y. 1998: Modulation of the tumor disposition of vinca alkaloids by PSC 833 in vitro and in vivo Journal of Pharmacology and Experimental Therapeutics 287(3): 963-968
Cui, P.-M.; Shu, L.; Liu, F.; Yang, J.-Q.; Song, Y.; Sun, W.-J. 2014: Anti-tumor effects of a novel cyclophosphamide derivate 9b in vivo and in vitro Yao Xue Xue Bao 49(1): 44-49
Kall, M.A.; Hellström, I. 1975: Specific stimulatory and cytotoxic effects of lymphocytes sensitized in vitro to either alloantigens or tumor antigens Journal of Immunology 114(3): 1083-1088
Pauli, B.U.; Anderson, S.N.; Memoli, V.A.; Kuettner, K.E. 1980: Development of an in vitro and in vivo epithelial tumor model for the study of invasion Cancer Research 40(12): 4571-4580
Allison, D.C.; Anderson, S.; Ridolpho, P.F.; Meyne, J.; Robertson, J. 1986: Alterations in the DNA metabolism of MCa-11 mouse mammary tumor cells grown in vivo and in vitro Cancer Research 46(8): 3951-3957
Bartholomew, J.S.; Glenville, S.; Sarkar, S.; Burt, D.J.; Stanley, M.A.; Ruiz-Cabello, F.; Chengang, J.; Garrido, F.; Stern, P.L. 1997: Integration of high-risk human papillomavirus DNA is linked to the down-regulation of class I human leukocyte antigens by steroid hormones in cervical tumor cells Cancer Research 57(5): 937-942
Sakamoto, J.; Furukawa, K.; Cordon-Cardo, C.; Yin, B.W.; Rettig, W.J.; Oettgen, H.F.; Old, L.J.; Lloyd, K.O. 1986: Expression of Lewisa, Lewisb, X, and y blood group antigens in human colonic tumors and normal tissue and in human tumor-derived cell lines Cancer Research 46(3): 1553-1561